Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Elliott

Showing results (881-890 of 905) with videos related to

Pageof 91
Sort By:
Nature Communications|March 13, 2021
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypesJames A Diao, Jason K Wang, Wan Fung Chui, et al.
Journal of Medicinal Chemistry|October 23, 1998
Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitorsD H Boschelli, Z Wu, S R Klutchko, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Journal of Medicinal Chemistry|February 17, 2006
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptorsSylvester R Klutchko, Hairong Zhou, R Thomas Winters, et al.
Nature Aging|April 2, 2021
Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policyMaxwell L Elliott, Avshalom Caspi, Renate M Houts, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
The New Phytologist|November 27, 2023
Global analysis of Poales diversification - parallel evolution in space and time into open and closed habitatsTammy L Elliott, Daniel Spalink, Isabel Larridon, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
CBE Life Sciences Education|April 29, 2017
Broadening Participation in Biology Education Research: Engaging Community College Students and FacultyJeffrey N Schinske, Virginia L Balke, M Gita Bangera, et al.
Journal of Medicinal Chemistry|December 14, 2011
Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylaseKevin D Freeman-Cook, Paul Amor, Scott Bader, et al.
Pageof 91

Showing results (881-890 of 905) with videos related to

Sort By:
Pageof 91
Nature Communications|March 13, 2021
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypesJames A Diao, Jason K Wang, Wan Fung Chui, et al.
Journal of Medicinal Chemistry|October 23, 1998
Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitorsD H Boschelli, Z Wu, S R Klutchko, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Journal of Medicinal Chemistry|February 17, 2006
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptorsSylvester R Klutchko, Hairong Zhou, R Thomas Winters, et al.
Nature Aging|April 2, 2021
Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policyMaxwell L Elliott, Avshalom Caspi, Renate M Houts, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
The New Phytologist|November 27, 2023
Global analysis of Poales diversification - parallel evolution in space and time into open and closed habitatsTammy L Elliott, Daniel Spalink, Isabel Larridon, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
CBE Life Sciences Education|April 29, 2017
Broadening Participation in Biology Education Research: Engaging Community College Students and FacultyJeffrey N Schinske, Virginia L Balke, M Gita Bangera, et al.
Journal of Medicinal Chemistry|December 14, 2011
Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylaseKevin D Freeman-Cook, Paul Amor, Scott Bader, et al.
Pageof 91